Publikationen W. Löscher
Balta, D., Varghese, A., Prieto Huarcaya, S., Di Spiezio, A., Marques, A. R. A., Akdaş, E. Y., Tabakacilar, D., Drobny, A., Werner, C., Xiang, W., Mächtel, R., Dobert, J. P., Fejtova, A., Richter, F., Küspert, M., Arnold, P., Saftig, P., & Zunke, F. (2025). Recombinant cathepsins B and L promote α-synuclein clearance and restore lysosomal function in human and murine models with α-synuclein pathology. Molecular Neurodegeneration, 20, Article 95. https://doi.org/10.1186/s13024-025-00886-1
Details anzeigen
Details anzeigen
Diaz Santamaria, M. T., Gebel, E., Lau, K., Kotzur, R., Feja, M., Büning, H., & Richter, F. (2025). Developing nose-to-brain delivery of AAV2-mediated gene-therapy for neurodegenerative diseases. In 18th Graduate School Day: 21 November 2025 : abstract book (ZSN P 09). Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen
Details anzeigen
Drath, I., Richter, F., & Feja, M. (2025). Nose-to-brain drug delivery: from bench to bedside. Translational Neurodegeneration, 14, Article 23. https://doi.org/10.1186/s40035-025-00481-w
Details anzeigen
Details anzeigen
Feja, M., Drath, I., Weiß, S., Ewe, A., Gericke, B., Outeiro, T. F., Stefanis, L., Aigner, A., & Richter, F. (2025). Nose-to-brain siRNA delivery by PEI/PPI-based nanoparticles reduces α-synuclein expression in a Parkinson’s disease mouse model. Molecular Therapy: Nucleic Acids, 36(3), Article 102671. https://doi.org/10.1016/j.omtn.2025.102671
Details anzeigen
Details anzeigen
Greimel, E., Waltl, I., Busker, L., Pavlou, A., Käufer, C., Höglinger, G., Richter, F., & Kalinke, U. (2025). The impact of central nervous system viral infection on Parkinson’s disease pathogenesis. In 18th Graduate School Day: 21 November 2025 : abstract book (ZSN P 11). Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen
Details anzeigen
Hartke, A.-S., Schreiber, C. S., Lau, K., Wiesweg, I., Waltl, I., Kalinke, U., Richter, F., & Käufer, C. (2025). Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins. Neurobiology of Disease, 205, Article 106773. https://doi.org/10.1016/j.nbd.2024.106773
Details anzeigen
Details anzeigen
Höllerhage, M., Duan, L., Chua, O. W. H., Moebius, C., Bothe, S. H., Losse, K., Kotzur, R., Lau, K., Hopfner, F., Richter, F., Wahl-Schott, C., Bickle, M., & Höglinger, G. U. (2025). A genome-wide RNA interference screening reveals protectiveness of SNX5 knockdown in a Parkinson’s disease cell model. Translational Neurodegeneration, 14(1), Article 27. https://doi.org/10.1186/s40035-025-00486-5
Details anzeigen
Details anzeigen
Käufer, C., Stanojlović, M., Schidlitzki, A., Bonsberger, J., Storch, A., & Richter, F. (2025). Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathy. Journal of Parkinson’s Disease: JPD, 15(2), 311–328. https://doi.org/10.1177/1877718X241310723
Details anzeigen
Details anzeigen
Lai, T. T., Xiang, W., Stanojlovic, M., Käufer, C., Feja, M., Lau, K., Zunke, F., & Richter, F. (2025). The basolateral amygdala and striatum propagate alpha-synuclein pathology causing increased fear response in a Parkinson’s disease model. Brain, Behavior, and Immunity: An International Journal, 128, 469–486. https://doi.org/10.1016/j.bbi.2025.04.025
Details anzeigen
Details anzeigen
Schreiber, C. S., Ramil, L. N., Bieligk, J., Meineke, R., Käufer, C., & Richter, F. (2025). Intravenous SARS-CoV-2 Spike protein induces neuroinflammation and alpha-synuclein accumulation in brain regions relevant to Parkinson’s disease. Brain, Behavior, and Immunity: An International Journal, 129, 102–123. https://doi.org/10.1016/j.bbi.2025.05.021
Details anzeigen
Details anzeigen



